Home
>
National Drug Code (NDC)
>
ZIRGAN
ZIRGAN - 24208-535-35 - (ganciclovir)
Drug Information of ZIRGAN
| Product NDC: | 24208-535 |
| Proprietary Name: | ZIRGAN |
| Non Proprietary Name: | ganciclovir |
| Active Ingredient(s): | 1.5 mg/g & nbsp; ganciclovir |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ZIRGAN
| Product NDC: | 24208-535 |
| Labeler Name: | Bausch & Lomb Incorporated |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022211 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100430 |
Package Information of ZIRGAN
| Package NDC: | 24208-535-35 |
| Package Description: | 1 TUBE, WITH APPLICATOR in 1 CARTON (24208-535-35) > 5 g in 1 TUBE, WITH APPLICATOR |
NDC Information of ZIRGAN
| NDC Code | 24208-535-35 |
| Proprietary Name | ZIRGAN |
| Package Description | 1 TUBE, WITH APPLICATOR in 1 CARTON (24208-535-35) > 5 g in 1 TUBE, WITH APPLICATOR |
| Product NDC | 24208-535 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ganciclovir |
| Dosage Form Name | GEL |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20100430 |
| Marketing Category Name | NDA |
| Labeler Name | Bausch & Lomb Incorporated |
| Substance Name | GANCICLOVIR |
| Strength Number | 1.5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
